• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.在传达药物遗传学检测结果时保持平衡:促进理解并尽量减少不良心理和行为反应。
Patient Educ Couns. 2014 Oct;97(1):10-5. doi: 10.1016/j.pec.2014.06.007. Epub 2014 Jun 21.
2
Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report.先前遗传咨询和客观计算能力对准确解读药物遗传学检测报告的影响。
Public Health Genomics. 2021;24(1-2):26-32. doi: 10.1159/000512476. Epub 2021 Jan 14.
3
Community pharmacists' experience with pharmacogenetic testing.社区药剂师在药物基因检测方面的经验。
J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):587-594. doi: 10.1331/JAPhA.2015.15017.
4
Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.遗传咨询师和临床遗传学家对药物遗传学检测的使用和态度调查。
Clin Genet. 2012 Aug;82(2):115-20. doi: 10.1111/j.1399-0004.2012.01848.x. Epub 2012 Feb 19.
5
Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.精神药理学中的药物遗传学临床应用 - 药师、遗传咨询师、实施科学、临床医生和行业的观点。
Pharmacopsychiatry. 2020 Jul;53(4):162-173. doi: 10.1055/a-0975-9595. Epub 2019 Sep 11.
6
Public perspectives about pharmacogenetic testing and managing ancillary findings.公众对药物遗传学检测及处理辅助结果的看法。
Genet Test Mol Biomarkers. 2012 Mar;16(3):193-7. doi: 10.1089/gtmb.2011.0118. Epub 2011 Nov 2.
7
Collaborative Counseling Considerations for Pharmacogenomic Tests.药物基因组学检测的协作咨询注意事项。
Pharmacotherapy. 2017 Sep;37(9):990-999. doi: 10.1002/phar.1980. Epub 2017 Aug 7.
8
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.儿童和青少年精神科医生在临床实践中对基因检测和药物遗传学的使用、态度和理解。
Psychiatry Res. 2023 Jul;325:115246. doi: 10.1016/j.psychres.2023.115246. Epub 2023 May 6.
9
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.直接面向消费者的药物基因组检测与医生利用率的提高有关。
J Med Genet. 2014 Feb;51(2):83-9. doi: 10.1136/jmedgenet-2013-101909. Epub 2013 Dec 16.
10
Nurses' communication of pharmacogenetic test results as part of discharge care.护士作为出院护理的一部分对药物遗传学检测结果的沟通。
Pharmacogenomics. 2015;16(3):251-6. doi: 10.2217/pgs.14.173.

引用本文的文献

1
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study).一项关于在新加坡门诊诊所实施先发制药物基因组学检测的可行性研究(IMPT研究)。
Pharmacogenomics J. 2025 Mar 12;25(1-2):7. doi: 10.1038/s41397-025-00366-1.
2
Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice.克服障碍:在瑞士临床实践中实施药师主导的药物基因组学服务的策略。
Genes (Basel). 2024 Jul 1;15(7):862. doi: 10.3390/genes15070862.
3
Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices.真实世界药物基因组学检测现状评估:知情同意、患者教育及相关实践
Front Pharmacol. 2024 Feb 8;15:1355412. doi: 10.3389/fphar.2024.1355412. eCollection 2024.
4
Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors.不同接受血管紧张素转换酶抑制剂治疗的患者的药物基因组学知识和认识。
Pharmacogenomics. 2023 Dec;24(18):921-930. doi: 10.2217/pgs-2023-0191. Epub 2023 Dec 6.
5
Personalizing Personalized Medicine: The Confluence of Pharmacogenomics, a Person's Medication Experience and Ethics.个性化精准医疗:药物基因组学、个人用药体验与伦理学的融合
Pharmacy (Basel). 2023 Jun 15;11(3):101. doi: 10.3390/pharmacy11030101.
6
Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.社区药房的药物遗传学检测和咨询:一项新的由药剂师主导的服务的混合方法研究。
Int J Clin Pharm. 2023 Dec;45(6):1378-1386. doi: 10.1007/s11096-023-01596-8. Epub 2023 Jun 20.
7
Pharmacogenomics in practice: a review and implementation guide.实践中的药物基因组学:综述与实施指南。
Front Pharmacol. 2023 May 18;14:1189976. doi: 10.3389/fphar.2023.1189976. eCollection 2023.
8
A randomized controlled trial of analogue pharmacogenomic testing feedback for psychotropic medications.一项关于精神药物类似物药物基因组学检测反馈的随机对照试验。
PEC Innov. 2022 Dec 16;2:100119. doi: 10.1016/j.pecinn.2022.100119. eCollection 2023 Dec.
9
Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore.改善处方:新加坡初级医疗保健中基于临床决策支持的药物基因组学检测的可行性研究。
Fam Pract. 2024 Aug 14;41(4):477-483. doi: 10.1093/fampra/cmac124.
10
Preferences for and acceptability of receiving pharmacogenomic results by mail: A focus group study with a primarily African-American cohort.邮寄获取药物基因组学结果的偏好和可接受性:一项以非裔美国人为主的队列的焦点小组研究。
J Genet Couns. 2021 Dec;30(6):1582-1590. doi: 10.1002/jgc4.1424. Epub 2021 Apr 19.

本文引用的文献

1
Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.药剂师对药物基因检测的知识、态度和教育情况。
Per Med. 2012 Jan;9(1):19-27. doi: 10.2217/pme.11.87.
2
Comparison of delivery strategies for pharmacogenetic testing services.比较药物遗传学检测服务的不同传递策略。
Pharmacogenet Genomics. 2014 Mar;24(3):139-45. doi: 10.1097/FPC.0000000000000028.
3
Antidepressant pharmacogenetics.抗抑郁药的药物遗传学。
Curr Opin Psychiatry. 2014 Jan;27(1):43-51. doi: 10.1097/YCO.0000000000000023.
4
Delivering pharmacogenetic testing in a primary care setting.在基层医疗环境中开展药物遗传学检测。
Pharmgenomics Pers Med. 2013 Sep 18;6:105-12. doi: 10.2147/PGPM.S50598. eCollection 2013.
5
Checking for comprehension: mastering teach-back techniques.检查理解情况:掌握反馈教学法。
Consult Pharm. 2013 Sep;28(9):550-4. doi: 10.4140/TCP.n.2013.550.
6
The potential impact of pharmacogenetic testing on medication adherence.药物遗传学检测对药物依从性的潜在影响。
Pharmacogenomics J. 2013 Dec;13(6):481-3. doi: 10.1038/tpj.2013.33. Epub 2013 Sep 3.
7
Impact of direct-to-consumer genomic testing at long term follow-up.直接面向消费者的基因组检测在长期随访中的影响。
J Med Genet. 2013 Jun;50(6):393-400. doi: 10.1136/jmedgenet-2012-101207. Epub 2013 Apr 4.
8
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.临床药物遗传学实施联盟指南:CYP2D6 和 CYP2C19 基因型与三环类抗抑郁药剂量
Clin Pharmacol Ther. 2013 May;93(5):402-8. doi: 10.1038/clpt.2013.2. Epub 2013 Jan 16.
9
Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.影响口服抗癌药物用药依从性和持久性的决定因素和相关因素:系统评价。
Cancer Treat Rev. 2013 Oct;39(6):610-21. doi: 10.1016/j.ctrv.2012.12.014. Epub 2013 Feb 19.
10
What you need to know about pharmacogenomics.
Nursing. 2013 Mar;43(3):44-8; quiz 49. doi: 10.1097/01.NURSE.0000426621.59131.e5.

在传达药物遗传学检测结果时保持平衡:促进理解并尽量减少不良心理和行为反应。

Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

作者信息

Haga Susanne B, Mills Rachel, Bosworth Hayden

机构信息

Institute for Genome Sciences & Policy and Sanford School of Public Policy, Duke University, Durham, USA.

Institute for Genome Sciences & Policy, Duke University, Durham, USA.

出版信息

Patient Educ Couns. 2014 Oct;97(1):10-5. doi: 10.1016/j.pec.2014.06.007. Epub 2014 Jun 21.

DOI:10.1016/j.pec.2014.06.007
PMID:24985359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4162835/
Abstract

OBJECTIVE

Pharmacogenetic (PGx) testing can provide information about a patient's likelihood to respond to a medication or experience an adverse event, and be used to inform medication selection and/or dosing. Promoting patient comprehension of PGx test results will be important to improving engagement and understanding of treatment decisions.

METHODS

The discussion in this paper is based on our experiences and the literature on communication of genetic test results for disease risk and broad risk communication strategies.

RESULTS

Clinical laboratory reports often describe PGx test results using standard terminology such as 'poor metabolizer' or 'ultra-rapid metabolizer.' While this type of terminology may promote patient recall with its simple, yet descriptive nature, it may be difficult for some patients to comprehend and/or cause adverse psychological or behavioral responses.

CONCLUSION

The language used to communicate results and their significance to patients will be important to consider in order to minimize confusion and potential psychological consequences such as increased anxiety that can adversely impact medication-taking behaviors.

PRACTICE IMPLICATIONS

Due to patients' unfamiliarity with PGx testing and the potential for confusion, adverse psychological effects, and decreased medication adherence, health providers need to be cognizant of the language used in discussing PGx test results with patients.

摘要

目的

药物遗传学(PGx)检测能够提供有关患者对药物产生反应或出现不良事件可能性的信息,并用于指导药物选择和/或剂量确定。提高患者对PGx检测结果的理解对于增强其对治疗决策的参与度和理解至关重要。

方法

本文的讨论基于我们的经验以及关于疾病风险基因检测结果沟通和广泛风险沟通策略的文献。

结果

临床实验室报告通常使用“代谢缓慢者”或“超快代谢者”等标准术语来描述PGx检测结果。虽然这类术语因其简单却具有描述性的特点可能有助于患者记忆,但对一些患者来说可能难以理解,和/或引发不良的心理或行为反应。

结论

为尽量减少混淆以及诸如焦虑增加等可能对用药行为产生不利影响的潜在心理后果,考虑用于向患者传达检测结果及其意义的语言非常重要。

实践意义

由于患者对PGx检测不熟悉,且存在混淆、不良心理影响以及用药依从性降低的可能性,医疗服务提供者在与患者讨论PGx检测结果时需要注意所用的语言。